{"id":48987,"date":"2022-09-29T18:01:37","date_gmt":"2022-09-29T16:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/australia-regenerative-medicine-market-report-2022-expanding-healthcare-infrastructure-and-increasing-evolution-in-the-pharmaceutical-sector-drives-sector-researchandmarkets-com\/"},"modified":"2022-09-29T18:01:37","modified_gmt":"2022-09-29T16:01:37","slug":"australia-regenerative-medicine-market-report-2022-expanding-healthcare-infrastructure-and-increasing-evolution-in-the-pharmaceutical-sector-drives-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/australia-regenerative-medicine-market-report-2022-expanding-healthcare-infrastructure-and-increasing-evolution-in-the-pharmaceutical-sector-drives-sector-researchandmarkets-com\/","title":{"rendered":"Australia Regenerative Medicine Market Report 2022: Expanding Healthcare Infrastructure and Increasing Evolution in the Pharmaceutical Sector Drives Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Australia Regenerative Medicine Market, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nAustralia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure and increasing evolution in the pharmaceutical sector to design advanced drugs. Besides, increasing research & development activities to advance pharmaceutical products and find curative therapies for unknown diseases are contributing to the growth of Australia regenerative medicine market.\n<\/p>\n

\nRegenerative medicines aid the replacement, engineering, or regeneration of human or animal cells. The drugs aid in the restoration of normal cell function. Regenerative medicines stimulate the body’s repair system to heal irreparable tissues and organs to restore functions. Regenerative medicine has the potential to be used for the artificial generation of tissues and organs in the laboratory, which can then be safely implanted if the body is unable to heal under certain conditions. Cell therapy, immunomodulation therapy, and tissue engineering are examples of biomedical techniques and clinical therapies used in regenerative medicine.\n<\/p>\n

\nRegenerative medicines are advanced pharmaceuticals undergoing continuous research and product development to provide better healthcare and patient care services. Biomedical methods such as cell therapy, immunomodulation therapy, and tissue engineering are becoming more common as medicine advances, fueling the growth of the Australia regenerative medicine market over the next five years.\n<\/p>\n

\nFurthermore, increased investment in these biomedical procedures and research will help the Australia regenerative medicine market grow over the next five years. Australia Department of Industry, Innovation, and Science has provided a USD60 million grant through the CTM CRC to develop integrated, cost-effective, and accessible cell therapies that have further revolutionized regenerative medicine.\n<\/p>\n

\nThe rise in chronic neurological diseases and cancers that necessitate advanced medical treatment is anticipated fuel the growth of the Australia regenerative medicine market over the next five years. Regenerative medicine is being used to treat Alzheimer’s disease, Parkinson’s disease, cardiovascular disorders (CVDs), osteoporosis, and spinal cord injuries, fueling the market growth. Furthermore, the country’s growing geriatric population, which is prone to diseases such as musculoskeletal, oncological, dermatological, and cardiological disorders, is aiding Australia’s regenerative medicine market’s growth over the next five years.\n<\/p>\n

\nThe Australia regenerative medicine market is segmented by type, application, end user, competitional landscape, and regional distribution. Based on type, the market is further divided into cell therapy, gene modification, tissue engineering, and others. The cell therapy segment is anticipated to hold the largest share in the Australia regenerative medicine market, owing to rising demand and dependability over cell therapy in the biomedical processes.\n<\/p>\n

\nReport Scope:<\/strong>\n<\/p>\n

\nIn this report, Australia regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:\n<\/p>\n

\nAustralia Regenerative Medicine Market, By Type:<\/strong>\n<\/p>\n